Search | Search by Center | Search by Source | Keywords in Title
Valle LF, Nickols NG, Yamoah K, Garraway IP, Maxwell KN, Lynch JA. In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer". The Oncologist. 2023 Nov 2; 28(11):e1129-e1130.
This letter to the editor responds to comments by Sartor et al regarding recent findings on the clinical relevance of CDK12 pathogenic mutations.